{"ticker": {"uuid": "a18efe09-40e4-4818-af70-795a0b494dba", "symbol": "R1MD34", "name": "ResMed Inc.", "exchange": "SAO", "country": "BR", "sector": "Healthcare", "industry": "Medical Instruments & Supplies"}, "articles": [{"title": "ResMed chairman & CEO Michael Farrell sells $1.09m in company stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQSnpXcnc5cDRZR19qRDFfSlJxd3pXZzdfbG1FT1hSTU1yelVaSFY2S0hib3owSlpvUVNlNDI2bm9iRlBJdHFCRWZ2VzdCdjhCdzVHcTVKRHpoUE1aTGZnaEEzNDVlQzlaelBDdllQd05XVElYc2NQdk9Da29FdjZ0bW10RjRJQjdNaG1WNzg2TEViZ2lyMkxqOUc3RjRKZGpCYlJIYnA5N0FncXowdGc5bVdUYU5zc3VjUDEwOXhXMFd1RU15a0xOeQ?oc=5", "source_name": "Investing.com", "published_at": "2026-07-09T12:44:41+00:00", "published_display": "09 Jul 2026 12:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is ResMed Inc (RMD) a Bargain After 6.3% Drop? GF Value Says Und", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNY1JyRTRVOXczcnE2X1BQUkhJRzZyVDNra1kxYVRtMkQtaXViZks0dm9SRE4wOTZMSE52WWt0d1BFRHJkQ1dhTU9pdXM0dTBYYWlhaElob0t0cGJHUHhXWGVDZkJZZmpoMTRPcl93UWgwSEY2VEVTS3VUOU42SFVOOUtxakFHRUo0dkpIX0h0bk9OdnlDNnkwN2ZYbzRENzRDNzFYMWpRSUVTZw?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-08T22:33:19+00:00", "published_display": "08 Jul 2026 22:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ResMed stock held at Hold by Needham as MatrixCare sale announced", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQdEpGdXZmemZHakNIbFg2b3B2Q2JFLU1vME9KQXFKMk1ZRnhYeFVCWVM3Z1BqSWpsbWlxbWg2QWIycVB1c0JYWEtjZWd0TmY3SDk3XzBoazhnNW0tZkFFWGFlQVpsQ2J4ekp4Ql9SMWV0dDhlNlFLN3VsSFR3Y2pfamx0T2ZGZDBhdUtqemFXWnBfNWFjblgxc21pSWlLWDQtalRHR2N3UmhWTkJGcktkQnltN2dvUkRUOFVCQi1Xdnc4dWc?oc=5", "source_name": "Investing.com", "published_at": "2026-07-08T15:34:36+00:00", "published_display": "08 Jul 2026 15:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ResMed Inc (RMD) Shares Surge 4.2% -- What GF Score of 90 Tells Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPSFd0enVXRG9MUXBnRmxjX3dpQnRmWV9IQ1hzZnh3NF85a3lTMmVqLXFBcmszNjJqWWZ4Z0gyek5idDgzdWk3OTM5QjF0eFFoaVhJMkx1d0xfdktBUDNRaF9HM0hSUjBGd3hDNURTMGNEWkczWkNhU1VEV2RPZVlOYXJKeTlXNUJtTUpvajRPZ2tHQUNqSzJ5LXA2WFNyWWNaYU1EVXZ6YkE?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ResMed Inc (RMD) Stock Down 3.9% -- Now Undervalued? GF Score: 9", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNaGNXUFduUHYtcG1TQk5YcnVXQ29sVnAtcHd0Qmxocm8wZU5abzRDWEUxaXE3M0JoVHNLZGhaVVVpZGE0S2tVSTdfMVJrTGdoUU1JdUo3Zk1hdElIbVRQNkhoU0NPWnZOVl9BYU1MYTFRUVBDX3NaVHRrQzhHUmdsalRUaTRLUXlvSTNlNGZiajhKNzBCVk5lbVRxdUxlbDVUWjFjcmdXaktfLUliMC1N?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Morgan Stanley downgrades ResMed stock rating on margin concerns", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOY0pRTURZMk9pWGJNbV9oeWZUNGwxRGZwNEdTVlhBZnhhdUxWak9sNkNKck4xSXMzd2Vza0M0MEFmc1BnQU5QNDNXS3NiU1UxYXFQTzZPOUVWLW5PNGxiaGhYMzJRaXJiYktvR1k1QldMN3dHbzI2amwwWnFlVF9PSkUtVzlNcTdsOWxwUkdkWkFZRXEtaG1SdC1UWDJjQmpEV0VucHJPRHZSYzVETEZGdUk1OWRkQWVrb2o2RHVDajhvQQ?oc=5", "source_name": "Investing.com", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is ResMed Stock Underperforming the Dow?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxPZVF0N0lFaGxKX2NQYVMtRWhodzFqaV9pWWhOZG56OFNNbXhUUDFCX0ZTNU5ZdjZqVFBMcUtRS0t4a0hqR09MWGFrNjV6aE9vb2dSRl84dTVwR3NBemNfbUdoZTFBRjFLWFpNVE9iRWhjcnpSUXg0ZFBzVXNwOWkyNUVQdFlOQms3aTJJ?oc=5", "source_name": "Barchart.com", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Resmed Inc at William Blair Growth Stock Conference Transcript", "summary": "", "url": "https://news.google.com/rss/articles/CBMia0FVX3lxTE5WeVBBOURpRkFSLVp4OG85THV2bnJCT3ROWjdLRGhGQ3NIdzFIM25qU25EY3F3TGRSY1dqdks1aUxGUVQ3aEo0MXNaWWZhdWdHWkh4SzRPS0FGcGhFYnBuSXpHbXRhSUcxOU5F?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ResMed Inc (RMD) Stock Down 6.3% -- Now Undervalued? GF Score: 9", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxObVZLS3NPaEZ1OE1ManZ1MDlrREUwN3JzRkZDSDFkXzVLMHR5anhwNlJycW5HcU9YanR1Ym1sMlg3YmxYaUlRVjRUYl9nZWl2TDl2dk93cUk0Ymh3TlZEVS1LaDhKZ1M3ZzdiV1hiRC1hZHozbTNrQXo4QmxiVGpTZ3NoMzdPMHRPLVdyMVZydXpMVUIzNEd6VEtPSmluakM2WFRWczRGTW5LOGswVmxV?oc=5", "source_name": "GuruFocus", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ResMed stock hits 52-week low at $198.60 amid challenging year", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOdmdQSWZqcVU1MDZDVmNiYVM5ckxiaElSUzBQdERGVjd0YnlJdi1uSWs3Y0J6TGZlY19XS0tBSWJxRUY3eEZoS3lCbXd2NHNDZ0NWd2lHVlB2R05iOTRXcWdIOTVHcWtRaDA1THZTUGZHbmVuUUJXOFB4Rm1jOU9HckhRWVBTWFFQdnlZOFJmRlBvYnBzdHEtRFQteXRybzJseDhMenp4MGdoZmZuNHRPcTRLSFBGd28?oc=5", "source_name": "Investing.com", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Needham reiterates Hold on ResMed stock on Noctrix acquisition", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPZWk2NWxhZTVCc0Q2OTA0dUw5NkhkdTA1bk9yYUZsX2phaHZUWGN0WGpaV05qOXhjMTRmdURNQ0RLa2UxX09FWmZTOFBmODFNUjFycDdvYWJnZVBsY0tMbXFxQVBzWnpoWFF0YVpWV1RHY1AzaTFWZkdPY2ZOWHc0UzRRMEVMVFVtRnNCd2hYUHZtaUlLQzYzWU9ZS3RYOEswamkzU3dVVjRWNHlTU2hyRTF0VzhyS0ZMOEF5eHd2Yw?oc=5", "source_name": "Investing.com", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ResMed chairman and CEO Michael Farrell sells $1 million in stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNYjZKZlZTUWVKcFVrVUw4RXpJNWs0ejJZUXdSaF82MWFhTHh0ZUw2Q1Q2azFWcWY1T0dwN2JXYVh6YWNJYXhmTWNDMHRnenBJejNDNndveTR5VXByNEhtOC1mTGJDalF6c2VTa2pDREZYNEc5aXNCcEt4YXFDc3J1ZTZGcGhnQTIyWmhHZWd4dHRzTTN4QUFYTWZONnpRQkFwckVCRl9qWGFpOWFNN19VZTlHRFNoRmZLV2l3N3RfM1JTNTB2TkhWdw?oc=5", "source_name": "Investing.com", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RBC Capital raises ResMed stock price target to $321 on growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNT1VMcWhuUkt0SHlCODBUVDFsZmw3aXByc1c3b2M4VkJNWXZ4LTN5bm8tNTFXdVM5Z3d1MWFNRUR3amJOXzJVZ2lUMjlCdHZMbjJuRVJDTEN6dTI4VGIwN3V2bHktSnI1eEF3bGRObkllbXVpUFQxOGFIcFN0WU81dHI1eENIdjRYeTNPUHltbmV3SFpUTC10cWptWjRCTU5RYlpIdG16QXh4ZmZsR2h2UUlvX0tOWFpWOTZCelNR?oc=5", "source_name": "Investing.com", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ResMed stock hits 52-week low at $205.86 amid market challenges", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQM084LUM3TFNtQXBjeEtRUFp4TmVnWHkyLVpmVFRaQTJJdl9KcV9wNVVtbmFfUWVONUNoQUVUZFFzc1NRbTEtR3U1ZFRzMkxoQmtDY0o2WHZmd2tIUFB4NF9idlJVNHlnWFI5eW5YeVB1U3JxVUtLeUVmOF85TlZTNThiR01DWE9meWFFU1Z1RUk4YUw5VG5rM2t4MEEwV2xLTDlPRFpGSXNkaDhUQmhmM2xCSGpGbnBu?oc=5", "source_name": "Investing.com", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wolfe Research cuts ResMed stock price target on growth outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNazhsTlBOMW5lU0FWVXVweHlfNE0xc3NqbEVmdGRSLUJBNGFiYlNjb3k4OWowZUpuc0lfVmFpSGctYlJOeFpKbl9mdG1RWlFKSkdiTWVVQWdoQlFyS2Y4QkItU2dMTjdPUUZrbS0xMEwzR2puNFMwTmxJV3FrMEpYaFhNdkZmRFdFVUlzS0FaaWplRmZYaTF2cFBWQ0g3Z2dKRi1FMU1xLVBXZDRkc210VFo0M3FxNlBLYmFkd2pnU2Q?oc=5", "source_name": "Investing.com", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ResMed (RMD) Q3 2026 Earnings Transcript", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNV2pqQjNhSjFMM3lXT1lMS0J0akJnUzBISWdPWGQ4YWVBWmJxYkF1UlhsclNlVHJnaTIycU94NHNuVmU5TUVta2x5djN0cmlfeDhZUFY0VGo2a19FVVRZWFJVRS0tQjVkM1FMVl9UdS1CU1Q5OERYbFVFRnc5TWtMX01qdV94bVFaQ0ZlZkFjb0dxR1EyZ0VvZV9HZ1g4Zw?oc=5", "source_name": "The Motley Fool", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: ResMed Q3 2026 reports mixed results, stock steady", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxQajNJdEtQR2tKdXJXRFhkd0hOWnJwMnNscWp5bWNGMlhFY0NFMFVFNEgzaXhjb2RReWVXYmRfTXdlX094Nk4xcWhROTNkZ1pQQVdjdnJjNHdwTENNeVpmelE4SlREQVI1SzZnSTBqcGRFVVNadHBOaWNLWUo4U19YODNQT3V1eG1SQU82X3ZhVFBSYmZYTkt5WHdManRuV3NFQUxRVzJOYmh3OVZHWE93UVB4T0VVemRRMkxsdEJpQ2dpVVRXemVKM1lR?oc=5", "source_name": "Investing.com", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Morgan Stanley cuts ResMed stock price target on market competition", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNVVE5dEVqamQxWDRvaEpZUFdRVS1oTUlRcHNqa04yWmNFMWFJcTYtUS1vNDV0NGwtQ1hXR3kxaUtSaDRmc2VvNWl4XzFpSVhUWVF6NHpOS2MwWmRFVkxEZFRkZ0daNWRaUzdaSW1CekZCaTRVUHNRVzZfYTE5djE4UHdVWVZrbGpyNmFaQVU3aVpNc1MxeHNoekpjSUVUTHhfcElka2ZWQTlnMFVpRnVQUWh3VDVZbl94bXd1TnQxRmdJdGNVNFE?oc=5", "source_name": "Investing.com", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ResMed Inc stock hits 52-week low at 218.27 USD", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWEtGQ0FZVW5lWW5lSW8zNy1PcXJRSU8xRHlXbjFmMTB2ZjRKU3ZSOWhRS1V5LTFQZ0lQMkhPRjRtbnZCSkpEMWcyaHc2UldJV0RPWVJOY3hpZ0NEZFpVbXBnQ1ZfbnQ1aHdmLU9kM0JUR29BS3loNWppb0FjNnNPcVNLdHVFM2lMekNXaEc5QzE2aHFxbnZ3UWZ0VXR2VU1NX2JHNQ?oc=5", "source_name": "Investing.com", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Resmed director Farrell sells $502k in stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNRmZoUVRhR1J3Ym5na1ZQUzVpcW9nMy1oRzFCLUVSRjc5Vmh2cWlqTXhXMUQ5Mm1WXzlKUU9qdFBjTmpRTjlsR0lqQV83WEFDS2k4RXRFX0VpSF9tWlRlY2NUdnNUUDluNEtFY3hIT0FfdG1KYTdYQXZxWTNTbWFlMVhuWlNoUVFSREp1MlRwNldEZ1BxXzd1eWdfcVBpbXN3UklWV0MtVF9zYXN3?oc=5", "source_name": "Investing.com", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "ResMed chairman & CEO Michael Farrell sells $1.09m in company stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQSnpXcnc5cDRZR19qRDFfSlJxd3pXZzdfbG1FT1hSTU1yelVaSFY2S0hib3owSlpvUVNlNDI2bm9iRlBJdHFCRWZ2VzdCdjhCdzVHcTVKRHpoUE1aTGZnaEEzNDVlQzlaelBDdllQd05XVElYc2NQdk9Da29FdjZ0bW10RjRJQjdNaG1WNzg2TEViZ2lyMkxqOUc3RjRKZGpCYlJIYnA5N0FncXowdGc5bVdUYU5zc3VjUDEwOXhXMFd1RU15a0xOeQ?oc=5", "source_name": "Investing.com", "published_at": "2026-07-09T12:44:41+00:00", "published_display": "09 Jul 2026 12:44", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is ResMed Inc (RMD) a Bargain After 6.3% Drop? GF Value Says Und", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNY1JyRTRVOXczcnE2X1BQUkhJRzZyVDNra1kxYVRtMkQtaXViZks0dm9SRE4wOTZMSE52WWt0d1BFRHJkQ1dhTU9pdXM0dTBYYWlhaElob0t0cGJHUHhXWGVDZkJZZmpoMTRPcl93UWgwSEY2VEVTS3VUOU42SFVOOUtxakFHRUo0dkpIX0h0bk9OdnlDNnkwN2ZYbzRENzRDNzFYMWpRSUVTZw?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-08T22:33:19+00:00", "published_display": "08 Jul 2026 22:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ResMed stock held at Hold by Needham as MatrixCare sale announced", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQdEpGdXZmemZHakNIbFg2b3B2Q2JFLU1vME9KQXFKMk1ZRnhYeFVCWVM3Z1BqSWpsbWlxbWg2QWIycVB1c0JYWEtjZWd0TmY3SDk3XzBoazhnNW0tZkFFWGFlQVpsQ2J4ekp4Ql9SMWV0dDhlNlFLN3VsSFR3Y2pfamx0T2ZGZDBhdUtqemFXWnBfNWFjblgxc21pSWlLWDQtalRHR2N3UmhWTkJGcktkQnltN2dvUkRUOFVCQi1Xdnc4dWc?oc=5", "source_name": "Investing.com", "published_at": "2026-07-08T15:34:36+00:00", "published_display": "08 Jul 2026 15:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ResMed Inc (RMD) Shares Surge 4.2% -- What GF Score of 90 Tells Investors", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPSFd0enVXRG9MUXBnRmxjX3dpQnRmWV9IQ1hzZnh3NF85a3lTMmVqLXFBcmszNjJqWWZ4Z0gyek5idDgzdWk3OTM5QjF0eFFoaVhJMkx1d0xfdktBUDNRaF9HM0hSUjBGd3hDNURTMGNEWkczWkNhU1VEV2RPZVlOYXJKeTlXNUJtTUpvajRPZ2tHQUNqSzJ5LXA2WFNyWWNaYU1EVXZ6YkE?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ResMed Inc (RMD) Stock Down 3.9% -- Now Undervalued? GF Score: 9", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNaGNXUFduUHYtcG1TQk5YcnVXQ29sVnAtcHd0Qmxocm8wZU5abzRDWEUxaXE3M0JoVHNLZGhaVVVpZGE0S2tVSTdfMVJrTGdoUU1JdUo3Zk1hdElIbVRQNkhoU0NPWnZOVl9BYU1MYTFRUVBDX3NaVHRrQzhHUmdsalRUaTRLUXlvSTNlNGZiajhKNzBCVk5lbVRxdUxlbDVUWjFjcmdXaktfLUliMC1N?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Morgan Stanley downgrades ResMed stock rating on margin concerns", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOY0pRTURZMk9pWGJNbV9oeWZUNGwxRGZwNEdTVlhBZnhhdUxWak9sNkNKck4xSXMzd2Vza0M0MEFmc1BnQU5QNDNXS3NiU1UxYXFQTzZPOUVWLW5PNGxiaGhYMzJRaXJiYktvR1k1QldMN3dHbzI2amwwWnFlVF9PSkUtVzlNcTdsOWxwUkdkWkFZRXEtaG1SdC1UWDJjQmpEV0VucHJPRHZSYzVETEZGdUk1OWRkQWVrb2o2RHVDajhvQQ?oc=5", "source_name": "Investing.com", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is ResMed Stock Underperforming the Dow?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxPZVF0N0lFaGxKX2NQYVMtRWhodzFqaV9pWWhOZG56OFNNbXhUUDFCX0ZTNU5ZdjZqVFBMcUtRS0t4a0hqR09MWGFrNjV6aE9vb2dSRl84dTVwR3NBemNfbUdoZTFBRjFLWFpNVE9iRWhjcnpSUXg0ZFBzVXNwOWkyNUVQdFlOQms3aTJJ?oc=5", "source_name": "Barchart.com", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Resmed Inc at William Blair Growth Stock Conference Transcript", "summary": "", "url": "https://news.google.com/rss/articles/CBMia0FVX3lxTE5WeVBBOURpRkFSLVp4OG85THV2bnJCT3ROWjdLRGhGQ3NIdzFIM25qU25EY3F3TGRSY1dqdks1aUxGUVQ3aEo0MXNaWWZhdWdHWkh4SzRPS0FGcGhFYnBuSXpHbXRhSUcxOU5F?oc=5", "source_name": "GuruFocus", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ResMed Inc (RMD) Stock Down 6.3% -- Now Undervalued? GF Score: 9", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxObVZLS3NPaEZ1OE1ManZ1MDlrREUwN3JzRkZDSDFkXzVLMHR5anhwNlJycW5HcU9YanR1Ym1sMlg3YmxYaUlRVjRUYl9nZWl2TDl2dk93cUk0Ymh3TlZEVS1LaDhKZ1M3ZzdiV1hiRC1hZHozbTNrQXo4QmxiVGpTZ3NoMzdPMHRPLVdyMVZydXpMVUIzNEd6VEtPSmluakM2WFRWczRGTW5LOGswVmxV?oc=5", "source_name": "GuruFocus", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ResMed stock hits 52-week low at $198.60 amid challenging year", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOdmdQSWZqcVU1MDZDVmNiYVM5ckxiaElSUzBQdERGVjd0YnlJdi1uSWs3Y0J6TGZlY19XS0tBSWJxRUY3eEZoS3lCbXd2NHNDZ0NWd2lHVlB2R05iOTRXcWdIOTVHcWtRaDA1THZTUGZHbmVuUUJXOFB4Rm1jOU9HckhRWVBTWFFQdnlZOFJmRlBvYnBzdHEtRFQteXRybzJseDhMenp4MGdoZmZuNHRPcTRLSFBGd28?oc=5", "source_name": "Investing.com", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Needham reiterates Hold on ResMed stock on Noctrix acquisition", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPZWk2NWxhZTVCc0Q2OTA0dUw5NkhkdTA1bk9yYUZsX2phaHZUWGN0WGpaV05qOXhjMTRmdURNQ0RLa2UxX09FWmZTOFBmODFNUjFycDdvYWJnZVBsY0tMbXFxQVBzWnpoWFF0YVpWV1RHY1AzaTFWZkdPY2ZOWHc0UzRRMEVMVFVtRnNCd2hYUHZtaUlLQzYzWU9ZS3RYOEswamkzU3dVVjRWNHlTU2hyRTF0VzhyS0ZMOEF5eHd2Yw?oc=5", "source_name": "Investing.com", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ResMed chairman and CEO Michael Farrell sells $1 million in stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNYjZKZlZTUWVKcFVrVUw4RXpJNWs0ejJZUXdSaF82MWFhTHh0ZUw2Q1Q2azFWcWY1T0dwN2JXYVh6YWNJYXhmTWNDMHRnenBJejNDNndveTR5VXByNEhtOC1mTGJDalF6c2VTa2pDREZYNEc5aXNCcEt4YXFDc3J1ZTZGcGhnQTIyWmhHZWd4dHRzTTN4QUFYTWZONnpRQkFwckVCRl9qWGFpOWFNN19VZTlHRFNoRmZLV2l3N3RfM1JTNTB2TkhWdw?oc=5", "source_name": "Investing.com", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RBC Capital raises ResMed stock price target to $321 on growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNT1VMcWhuUkt0SHlCODBUVDFsZmw3aXByc1c3b2M4VkJNWXZ4LTN5bm8tNTFXdVM5Z3d1MWFNRUR3amJOXzJVZ2lUMjlCdHZMbjJuRVJDTEN6dTI4VGIwN3V2bHktSnI1eEF3bGRObkllbXVpUFQxOGFIcFN0WU81dHI1eENIdjRYeTNPUHltbmV3SFpUTC10cWptWjRCTU5RYlpIdG16QXh4ZmZsR2h2UUlvX0tOWFpWOTZCelNR?oc=5", "source_name": "Investing.com", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ResMed stock hits 52-week low at $205.86 amid market challenges", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQM084LUM3TFNtQXBjeEtRUFp4TmVnWHkyLVpmVFRaQTJJdl9KcV9wNVVtbmFfUWVONUNoQUVUZFFzc1NRbTEtR3U1ZFRzMkxoQmtDY0o2WHZmd2tIUFB4NF9idlJVNHlnWFI5eW5YeVB1U3JxVUtLeUVmOF85TlZTNThiR01DWE9meWFFU1Z1RUk4YUw5VG5rM2t4MEEwV2xLTDlPRFpGSXNkaDhUQmhmM2xCSGpGbnBu?oc=5", "source_name": "Investing.com", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wolfe Research cuts ResMed stock price target on growth outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNazhsTlBOMW5lU0FWVXVweHlfNE0xc3NqbEVmdGRSLUJBNGFiYlNjb3k4OWowZUpuc0lfVmFpSGctYlJOeFpKbl9mdG1RWlFKSkdiTWVVQWdoQlFyS2Y4QkItU2dMTjdPUUZrbS0xMEwzR2puNFMwTmxJV3FrMEpYaFhNdkZmRFdFVUlzS0FaaWplRmZYaTF2cFBWQ0g3Z2dKRi1FMU1xLVBXZDRkc210VFo0M3FxNlBLYmFkd2pnU2Q?oc=5", "source_name": "Investing.com", "published_at": "2026-05-01T07:00:00+00:00", "published_display": "01 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ResMed (RMD) Q3 2026 Earnings Transcript", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNV2pqQjNhSjFMM3lXT1lMS0J0akJnUzBISWdPWGQ4YWVBWmJxYkF1UlhsclNlVHJnaTIycU94NHNuVmU5TUVta2x5djN0cmlfeDhZUFY0VGo2a19FVVRZWFJVRS0tQjVkM1FMVl9UdS1CU1Q5OERYbFVFRnc5TWtMX01qdV94bVFaQ0ZlZkFjb0dxR1EyZ0VvZV9HZ1g4Zw?oc=5", "source_name": "The Motley Fool", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings call transcript: ResMed Q3 2026 reports mixed results, stock steady", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxQajNJdEtQR2tKdXJXRFhkd0hOWnJwMnNscWp5bWNGMlhFY0NFMFVFNEgzaXhjb2RReWVXYmRfTXdlX094Nk4xcWhROTNkZ1pQQVdjdnJjNHdwTENNeVpmelE4SlREQVI1SzZnSTBqcGRFVVNadHBOaWNLWUo4U19YODNQT3V1eG1SQU82X3ZhVFBSYmZYTkt5WHdManRuV3NFQUxRVzJOYmh3OVZHWE93UVB4T0VVemRRMkxsdEJpQ2dpVVRXemVKM1lR?oc=5", "source_name": "Investing.com", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Morgan Stanley cuts ResMed stock price target on market competition", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxNVVE5dEVqamQxWDRvaEpZUFdRVS1oTUlRcHNqa04yWmNFMWFJcTYtUS1vNDV0NGwtQ1hXR3kxaUtSaDRmc2VvNWl4XzFpSVhUWVF6NHpOS2MwWmRFVkxEZFRkZ0daNWRaUzdaSW1CekZCaTRVUHNRVzZfYTE5djE4UHdVWVZrbGpyNmFaQVU3aVpNc1MxeHNoekpjSUVUTHhfcElka2ZWQTlnMFVpRnVQUWh3VDVZbl94bXd1TnQxRmdJdGNVNFE?oc=5", "source_name": "Investing.com", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ResMed Inc stock hits 52-week low at 218.27 USD", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWEtGQ0FZVW5lWW5lSW8zNy1PcXJRSU8xRHlXbjFmMTB2ZjRKU3ZSOWhRS1V5LTFQZ0lQMkhPRjRtbnZCSkpEMWcyaHc2UldJV0RPWVJOY3hpZ0NEZFpVbXBnQ1ZfbnQ1aHdmLU9kM0JUR29BS3loNWppb0FjNnNPcVNLdHVFM2lMekNXaEc5QzE2aHFxbnZ3UWZ0VXR2VU1NX2JHNQ?oc=5", "source_name": "Investing.com", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Resmed director Farrell sells $502k in stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNRmZoUVRhR1J3Ym5na1ZQUzVpcW9nMy1oRzFCLUVSRjc5Vmh2cWlqTXhXMUQ5Mm1WXzlKUU9qdFBjTmpRTjlsR0lqQV83WEFDS2k4RXRFX0VpSF9tWlRlY2NUdnNUUDluNEtFY3hIT0FfdG1KYTdYQXZxWTNTbWFlMVhuWlNoUVFSREp1MlRwNldEZ1BxXzd1eWdfcVBpbXN3UklWV0MtVF9zYXN3?oc=5", "source_name": "Investing.com", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 59, "total_relevant": 20, "sentiment_summary": {"positive": 3, "negative": 1, "neutral": 16, "score": 52, "total": 20, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 83, "events": [{"event": "general", "label": "Market update", "weight": 7.15, "count": 13}, {"event": "earnings", "label": "Earnings", "weight": 1.65, "count": 3}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 3, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 245.5, "latest_week": "2026-07-10", "one_week_move": 0.0, "four_week_move": -0.7, "twelve_week_move": -12.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.940256, "market_dynamics_buy_signal": false, "relative_strength": -31.139764, "fair_value_gap": -17.7, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 26.9923, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.0% over one week, -0.7% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 51, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Investing.com", "count": 13}, {"label": "GuruFocus", "count": 5}, {"label": "Barchart.com", "count": 1}, {"label": "The Motley Fool", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 20}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 13}, {"label": "Earnings", "count": 3}, {"label": "Analyst action", "count": 2}, {"label": "Deals and strategy", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "83/100 classification confidence."}, {"label": "Company focus", "value": "20", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.0% over one week, -0.7% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "ResMed chairman & CEO Michael Farrell sells $1.09m in company stock"}], "updated_at": "2026-07-17T16:32:48.816336+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}